Quantification of NADH:ubiquinone oxidoreductase (complex I) content in biological samples.
Ontology highlight
ABSTRACT: Impairments in mitochondrial energy metabolism have been implicated in human genetic diseases associated with mitochondrial and nuclear DNA mutations, neurodegenerative and cardiovascular disorders, diabetes, and aging. Alteration in mitochondrial complex I structure and activity has been shown to play a key role in Parkinson's disease and ischemia/reperfusion tissue injury, but significant difficulty remains in assessing the content of this enzyme complex in a given sample. The present study introduces a new method utilizing native polyacrylamide gel electrophoresis in combination with flavin fluorescence scanning to measure the absolute content of complex I, as well as α-ketoglutarate dehydrogenase complex, in any preparation. We show that complex I content is 19 ± 1 pmol/mg of protein i
SUBMITTER: Ansari F
PROVIDER: S-EPMC8503622 | biostudies-literature | 2021 Oct
REPOSITORIES: biostudies-literature
ACCESS DATA